Latest News about EWTX
Recent news which mentions EWTX
FDA approves Reata’s rare disease drug amid questions about changes to the regulatory environment for neuroscience treatments
February 28, 2023
From MarketWatch
Why ZW Data Action Technologies Jumped 37%; Here Are 71 Biggest Movers From Yesterday
September 16, 2022
From Benzinga
Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday
September 14, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
August 25, 2022
From Benzinga
6 Blue-Chip Stocks to Sell Now
July 18, 2022
From InvestorPlace
From Benzinga
Stocks That Hit 52-Week Lows On Friday
March 25, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
March 24, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
March 23, 2022
From Benzinga
From Benzinga
From Benzinga
52 Biggest Movers From Friday
January 31, 2022
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 28, 2022
From Benzinga
33 Stocks Moving In Friday's Mid-Day Session
January 28, 2022
From Benzinga
50 Biggest Movers From Yesterday
January 06, 2022
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 05, 2022
From Benzinga
34 Stocks Moving In Wednesday's Mid-Day Session
January 05, 2022
From Benzinga
Edgewise Therapeutics Shares Jump After Positive Data On Becker Muscular Dystrophy Study
January 05, 2022
Tickers
EWTX
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Partner For Shingles Vaccine, Annexon Huntington Disease Study Disappoints, Amneal Buys Neurology Assets
January 05, 2022
From Benzinga
The Week Ahead In Biotech (Jan 2-Jan. 8): Stray Clinical Readouts In Focus In Slow News Week
January 02, 2022
From Benzinga
63 Biggest Movers From Friday
December 20, 2021
From Benzinga
60 Biggest Movers From Yesterday
December 07, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.